Source: Eur Respir J, 57 (4) 2004277; 10.1183/13993003.04277-2020
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Aida Llucià-Valldeperas, Jessie van Wezenbeek, Marie-José Goumans, Frances Sarah de Man. The battle of new biomarkers for right heart failure in pulmonary hypertension: is the queen of hearts NT-proBNP defeated at last?. Eur Respir J, 57 (4) 2004277; 10.1183/13993003.04277-2020

Member's Comments

No comment yet.

Related content which might interest you: Beta-blockers in pulmonary arterial hypertension: evolving concepts of right heart failure Source: Eur Respir J 2015; 46: 619-621 Year: 2015 Right heart failure in pulmonary hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart Source: Eur Respir Rev 2009; 19: 72-82 Year: 2010 Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes Source: Eur Respir J, 53 (3) 1801894; 10.1183/13993003.01894-2018 Year: 2019 Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes Source: Eur Respir J, 53 (3) 1802393; 10.1183/13993003.02393-2018 Year: 2019 Five-year survival after an acute episode of decompensated pulmonary arterial hypertension in the modern management era of right heart failure Source: Eur Respir J, 58 (3) 2100466; 10.1183/13993003.00466-2021 Year: 2021 Right heart imaging and failure in pulmonary hypertension Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017 Treatment of right heart failure on pulmonary arterial hypertension: is going left a step in the right direction? Source: Eur Respir Rev 2009; 19: 4-6 Year: 2010 Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm Source: Eur Respir J 2015; 46: 299-302 Year: 2015 Is right heart catheterisation still a fundamental part of the follow-up assessment of pulmonary arterial hypertension? The argument against Source: Eur Respir J, 52 (1) 1800996; 10.1183/13993003.00996-2018 Year: 2018 Late Breaking Abstract - Right heart structural changes, exercise capacity and stress induced right ventricle dysfunction in non- severe COPD patients without pulmonary hypertension at rest. Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD Year: 2018 Does heart failure make a difference in pulmonary function testing? Source: Virtual Congress 2020 – Unusual tools for evaluating obstructive diseases Year: 2020 Admission due to heart failure and pulmonary function testing: is there a COPD? Source: Virtual Congress 2021 – Comorbidities in airway obstructive diseases Year: 2021 Haemodynamics to predict outcome in pulmonary hypertension due to left heart disease: a meta-analysis Source: Eur Respir J, 51 (4) 1702427; 10.1183/13993003.02427-2017 Year: 2018 Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension Source: Eur Respir J 2010; 35: 1286-1293 Year: 2010 How to define pulmonary hypertension due to left heart disease Source: Eur Respir J 2016; 48: 553-555 Year: 2016 Pulmonary hypertension associated with left heart disease Source: Eur Respir Mon 2012; 57: 119-137 Year: 2012 CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension Source: Eur Respir J, 57 (4) 1901192; 10.1183/13993003.01192-2019 Year: 2021 Outcomes of hospitalisation for right heart failure in pulmonary arterial hypertension Source: Eur Respir J 2011; 38: 359-367 Year: 2011